Shuangqi Pharmaceutical

Inner Mongolia Shuangqi Pharmaceutical, a subsidiary of Jiangzhong Pharmaceutical and part of the China Resources (CR) Group, is a leading Chinese biopharmaceutical company specializing in microecological preparations. Established in 1994, the company is a pioneer in the research, development, and commercialization of live biotherapeutic products aimed at treating gastrointestinal disorders. Its flagship product, Golden Bifid (Bifidobacterium tetravaccine), is one of the most recognized probiotic medications in China for managing intestinal flora imbalance. Shuangqi leverages advanced fermentation and freeze-drying technologies to maintain high microbial viability in its formulations. The company operates modern GMP-certified manufacturing facilities in Hohhot to support its large-scale production needs and dominant market share in the Chinese digestive health sector.